Literature DB >> 21592228

Portal venous invasion: the single most independent risk factor for immediate postoperative recurrence of hepatocellular carcinoma.

Kang Kook Choi1, Sung Hoon Kim, Sae Byeol Choi, Jin Hong Lim, Gi Hong Choi, Jin Sub Choi, Kyung Sik Kim.   

Abstract

BACKGROUND AND AIM: Despite improvements of treatment in hepatocellular carcinoma (HCC), the recurrence rate after curative hepatic resection still remains remarkably high. An immediate recurrence of HCC after surgery is frustrating. We tried to clarify risks of immediate postoperative recurrence of HCC; that is, within 4 months after curative hepatic resection.
METHODS: A total of 167 patients with HCC underwent hepatic resection; 60 had immediate postoperative recurrences (IPR group), and 107 had disease-free survival for more than 5 years (DFS group). Variables were compared between the two groups.
RESULTS: Univariate analysis showed the following variables were significant risk factors for immediate postoperative recurrence of HCC: male sex, elevated serum aspartate aminotransferase level, greater amount of blood loss, longer operation time, worse tumor differentiation, higher tumor node metastasis stage, and presence of any of the following: intrahepatic metastasis, tumor-rupture, portal venous invasion, or microvascular invasion. In multivariate analysis, only portal venous invasion was a significant risk factor (odds ratio=3.2, P=0.03, standard error=0.5, Logistic regression analysis).
CONCLUSIONS: Portal venous invasion may be the most significant risk factor for immediate postoperative recurrence of HCC. However, accurate assessment of this risk factor may require histological examination, limiting its utility as a preoperative predictor. Further research is necessary to definitively identify preoperative predictors.
© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21592228     DOI: 10.1111/j.1440-1746.2011.06780.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  18 in total

1.  Microvascular infiltration has limited clinical value for treatment and prognosis in hepatocellular carcinoma.

Authors:  Nazario Portolani; Gian Luca Baiocchi; Sarah Molfino; Anna Benetti; Federico Gheza; Stefano Maria Giulini
Journal:  World J Surg       Date:  2014-07       Impact factor: 3.352

2.  Evaluation of the seventh edition of the American Joint Committee on Cancer tumour-node-metastasis (TNM) staging system for patients undergoing curative resection of hepatocellular carcinoma: implications for the development of a refined staging system.

Authors:  Albert C Y Chan; Sheung Tat Fan; Ronnie T P Poon; Tan To Cheung; Kenneth S H Chok; See Ching Chan; Chung Mau Lo
Journal:  HPB (Oxford)       Date:  2012-12-02       Impact factor: 3.647

3.  Adjuvant hepatic arterial infusion chemotherapy after hepatic resection of hepatocellular carcinoma with macroscopic vascular invasion.

Authors:  Hidetoshi Nitta; Toru Beppu; Katsunori Imai; Hiromitsu Hayashi; Akira Chikamoto; Hideo Baba
Journal:  World J Surg       Date:  2013-05       Impact factor: 3.352

4.  Caspase-Cleaved Cytokeratin 18 Fragment M30 as a Potential Biomarker of Macrovascular Invasion in Hepatocellular Carcinoma.

Authors:  Hatem Elalfy; Tarek Besheer; Mona M Arafa; Mona Abo-Bakr El-Hussiny; Mahmoud Abd El Latif; Sahar Alsayed Mohamed Alsayed
Journal:  J Gastrointest Cancer       Date:  2018-09

Review 5.  Adjuvant and chemopreventive therapies for resectable hepatocellular carcinoma: a literature review.

Authors:  Jian-Hong Zhong; Qing-Lian Zhong; Le-Qun Li; Hang Li
Journal:  Tumour Biol       Date:  2014-08-14

6.  CT Image-Based Texture Analysis to Predict Microvascular Invasion in Primary Hepatocellular Carcinoma.

Authors:  Yueming Li; Xuru Xu; Shuping Weng; Chuan Yan; Jianwei Chen; Rongping Ye
Journal:  J Digit Imaging       Date:  2020-09-23       Impact factor: 4.056

7.  A modified TNM-7 staging system to better predict the survival in patients with hepatocellular carcinoma after hepatectomy.

Authors:  Junting Huang; Yaojun Zhang; Zhenwei Peng; Hengjun Gao; Li Xu; Long R Jiao; Minshan Chen
Journal:  J Cancer Res Clin Oncol       Date:  2013-08-28       Impact factor: 4.553

8.  The impact of posthepatectomy liver failure on the recurrence of hepatocellular carcinoma.

Authors:  Kohta Iguchi; Etsuro Hatano; Kenya Yamanaka; Shiro Tanaka; Kojiro Taura; Shinji Uemoto
Journal:  World J Surg       Date:  2014-01       Impact factor: 3.352

9.  Cortactin is a sensitive biomarker relative to the poor prognosis of human hepatocellular carcinoma.

Authors:  Gang Zhao; Zi-ming Huang; Ya-Lin Kong; Dong-Qing Wen; Yu Li; Li Ren; Hong-Yi Zhang
Journal:  World J Surg Oncol       Date:  2013-03-21       Impact factor: 2.754

10.  Microvascular invasion (MVI) is a poorer prognostic predictor for small hepatocellular carcinoma.

Authors:  Min Du; Lingli Chen; Jing Zhao; Feng Tian; Haiying Zeng; Yunshan Tan; Huichuan Sun; Jian Zhou; Yuan Ji
Journal:  BMC Cancer       Date:  2014-01-24       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.